Syndeio Biosciences
Indianapolis
About Syndeio Biosciences
Syndeio Biosciences is a clinical-stage biotechnology company focused on developing therapies to restore and enhance synaptic health in central nervous system (CNS) disorders.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 11 – 50
- Total funding: $90.0M
- Last round: Series Unknown (May 2025)
- Website: syndeio.bio
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/syndeio-biosciences-113850 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.